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Regional Variation in the Expression of Bullous Pemphigoid Antigen 
and Location of Lesions in Bullous Pemphigoid 
DAVID J. GOLDBERG, M.D., MICHAEL SABOLINSKI, M.S., AND JEAN-CLAUDE BYSTRYN, M.D. 
Department of Dermatology, New York University School of Medicine, New York, N ew Yorl?, U.S.A. 
The expression of bullous pemphigoid (BP) antigen in 
different locations on the body was estimated from the 
highest dilution of BP sera giving a positive reaction at 
a site by indirect immunofluorescence. Three sera with 
high titers (640-1280) of BP antibodies against monkey 
and guinea pig esophagus were reacted with 46 speci-
mens of normal human skin. There was marked varia-
tion in the expression of BP antigen in skin obtained 
from different sites. The greatest expression of BP an-
tigen was in skin obtained from the flexor surfaces of 
the arm, leg, and thigh. All specimens from these sites 
reacted with high dilutions (1:640-1:2560) of BP anti-
bodies. BP antigen was expressed least in skin speci-
mens froi:n scalp, face, and extensor surface of the arm. 
No BP antigen could be demonstrated in 17% of speci-
mens from these locations and the remainder reacted 
only with low dilutions (1:40-1:160) of BP antibodies. 
Skin from trunk, knee, and extensor thigh had inter-
mediate amounts of BP antigen. Similar results were 
seen with all 3 BP sera. Similar reactions were observed 
in multiple skin specimens obtained from different sites 
in the same individual. Of note is that the greatest 
expression of BP antigen was in areas commonly in-
volved in this disease (flexural surfaces), whereas the 
least was seen in areas (scalp, face, extensor arm) which 
are rarely involved. The apparent correlation between 
the expression of BP antigen and the location of lesions 
in bullous pemphigoid, suggests that BP antigen expres-
sion may play a role in the distribution of skin lesions 
in this disease. 
Bullous pemphigoid is a vesiculobullous disease in which 
lesion production appears to involve autoantibodies to the 
bullous pemphigoid (BP) antigen [1-5], an antigen present 
within t he lamina Iucida in t he basement membrane zone of 
skin [6,7]. Autoantibodies to BP antigen are present in the sera 
of approximately 70- 80% of patients with bullous pemphigoid 
[8- 10]. Although clearly a disease expressing its lesions pre-
dominantly in flexural regions of the body [8], no explanation 
for t his geographic preference is known . 
This study was undertaken to ascertain whether regional 
variation in the expression of BP antigen plays a role in the 
location of clinical lesions in bullous pemphigoid. 
MATERIALS AND METHODS 
S kin 
Studies were perfomed on two sets of normal human skin. Thirty· 
four specimens were obtained from the edges of surgically excised, 
benign skin lesions. Another 12 specimens were collected from multiple 
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4-mm punch biopsies of normal skin in two cadavers taken within 48 
h of death . No skin was taken from patients with blistering or autoim-
mune diseases. All specimens were immediately frozen in liquid nitro-
gen, cut in 4 I'll sections on a cryostat, and tested within 48 h. 
Sera 
Sera from 3 pat ients with typical bullous pemphigoid by clinical, 
histologic, and immunofluorescence criteria were used. The titers of 
BP antibodies were 640-1280 when tested against monkey and guinea 
pig esophagus. 
Antisera-Conjugate 
Fluorescein -labeled goat antihuman lgG conjugate was used (Cappel 
Labs, Cochranville, Pennsylvania) . The concentration of antibody pro-
tein was 10 mg/ml, total protein 17.1 mg/ ml, and F /P ratio 2.98 mg/g. 
For use, t he conjugate was diluted 1:20 in phosphate-buffered saline 
(PBS) with 4% bovine salt albumin . 
Immu.no[lu.orescence Studies 
Immunofluorescence studies were performed by standard techniques 
as previously described [11]. Skin sections were incubated at room 
temperature with serial serum dilutions. After 30 min, the slides were 
washed for 10 min in PBS and reincubated for 30 min with fluorescein-
labeled conjugate. Specimens were then washed for an additional 30 
min in PBS and covered with 0.2 cc glycerin- PBS and examined witli 
a Zeiss binocular microscope equipped with a mercury lamp, fluorescein 
isothiocyanate exciter and #50 barrier filters. 
The expression of BP antigen was estimated from the highest 
dilution of BP antibody that reacted positively with the specimen (i.e., 
the end point t iter). 
All 46 skin specimens were tested with all 3 sera. 
RESULTS 
There was marked variation in the maximum dilution of 
bullous pemphigoid sera giving positive reactions when tested 
against normal skin obtained from different sites in different 
individuals. The end point titer ra nged from 0-2560 when the 
same BP serum was tested against 46 different specimens of 
normal human skin (Fig 1). 
To examine whether location on the epidermis influenced 
the expression of BP antigen, the results were reexamined after 
skin specimens had been grouped according to their location 
on the body. The results obtained with a single serum are 
presented in Fig 2 and illustrated in Fig 3a-h. The most 
important observations were that the expression of BP antigen 
in skin obtained from t he same anatomic location in different 
individuals was similar, whereas it varied markedly in skin 
obtained from different sites. 
The greatest expression ofBP antigen, as estimated from the 
end point titer of BP a ntibody with skin obtained from that 
location, was in skin obtained from flexural surfaces (ie., flexor 
arm, flexor thigh, and popliteal fossa). Thirteen specimens of 
skin were tested from these sites. All were positive at high 
dilutions (640-2560) of BP sera. In contrast, t he least expres-
sion of BP antigen was on the scalp, face, and extensor arm. 
Eighteen specimens were tested from these sites. No BP antigen 
cou ld be demonstrated in 3 (17%) specimens. In the remainder, 
low dilutions (40- 160) of BP sera were required to demonstrate 
BP antigen. Skin from trunk, knee, and extensor thigh had 
intermediate amounts of BP antigen. 
The results obtained with a ll 3 sera are summarized in Fig 4. 
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Although there were small differences in mean titers obtained 
with the 3 different sera, the general patterns were similar as 
summarized in Fig 4. 
To exclude the possibility that variations in the expression 
of BP antigen resulted from BP antigen heterogeneity [ll) or 
from variation between individuals rather than between differ-
ent sites on the body, we analyzed separately the expression of 
BP antigen in 12 of the skin specimens obtained from different 
locations in the same individual. Six specimens were obtained 
from different sites in each of 2 cadavers. The results (Fig 5) 
confirmed the findings seen in random samples of human skin. 
The greatest expression of BP antigen was again in flexural 
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FIG 1. Express ion of pemphigoid a n t igen in diffe rent specimens of 
human skin. Expression of BP a ntigen was measured from end-point 
t ite r o f serum contain ing a nt ibodies to BP antigen. Results obta ined 
with 3 different BP sera a re shown. 
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F IG 2. Express ion of BP an t igen in skin obta ined from different 
s ites in different. individuals . All specimens t ested wit h same serum 
(serum 2). 
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FIG 4 . Mea n express ion of pemphigoid a n tigen in huma n sk in as a 
fun ction of location on t he body. Each bar represent s the average BP 
antigen express ion in a ll skin specimens tested from the indicated area 
on the body with t he sa me BP serum. 
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FIG 5. Express ion of pemphigoid a nt igen in same individual. 
Expression of BP a ntigen in skin from 6 different sites in t he same 
individual. Resul ts obta in ed wit h 2 different individuals each tested 
with 3 different BP sera. 
surfaces (i.e., popliteal fossa and f1exor thigh) and the least on 
the scalp. The trunk and extensor surface of the ext remit ies 
showed intermediate expression of antigens. Similar results 
were obtained wit h bot h individuals. 
DISCUSSION 
The most important findings of t his study are that t here is 
regional variation in the expression of BP antigen in normal 
human skin and an apparent correlation between t he sites of 
greatest expression of t his antigen and the location of lesions 
in bullous pemphigoid. 
Although bullous pemphigoid is commonly accepted to be a 
F IG 3. Indirect immuno!1uorescence photomicrographs of BP an t igen express ion . Specimens of skin obtained from different sites on the 
epiderm were reacted with t he sa me BP serum. P hotographs a ll taken at a se rum di lution of 1:160. a , Poplitea l fossa; b, fl exura l t high; c, fl exu ra l 
a rm; d, knee; e, extensor t high;/, face; g, scalp; a nd h, extensor arm. There is strong basement membrane zone (BMZ) stai ning in a-c; irregula r 
BMZ staining pattern in d and e; and absent BMZ staining in f- h. (O rigina l magni fication X 312.) 
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disease of autoimmune nature, no reason for t he f1exural pre-
dominance of lesions in this disease has been advanced. In 
general, very li ttle is known about t he factors tha t influence 
the distribut ion of skin lesions in different immune diseases 
other t han a llergic cont act dermatit is. However, we have pre-
vious ly shown t hat a lterations in t he expression of pemphigus 
ant ige ns in different levels within t he epidermis may play a 
role in bullae location in superficial and deep pemphigus 
[1 2,13]. 
The results of this study show that there is marked regional 
variation in expression of BP a nt igen at different sites in 
human skin. Greatest expression of BP antigen was found in 
skin from fl exural t high, and f1 exural and popliteal fossa, sites 
commonly involved with lesions of bullous pemphigoid. Lesser 
expression of BP ant igens was present on t runk, knees, and 
extensor t high, a reas of the body less commonly involved in 
the disease. BP ant igen expression was minimal or absent on 
scalp, face, and extensor a rm, ra rely involved regions in bullous 
pemphigoid. These variat ions were not due to differences in 
antigen expression among individuals or resulting from BP 
a ntige n heterogenicity [11], since specimens obtained from the 
same location in different individuals all had approximately 
similar expression of BP antigens. Furthermore, multiple skin 
specimens from t he same individual showed simila r changes in 
BP ant igen expression in different regions on the body. 
The correlation between expression of BP antigen and loca-
t ion of lesions in t his disease strongly suggests that the distri -
but ion of lesions in bullous pemphigoid is influenced by regional 
vari ations in BP antigen expression. 
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